EJCTS Click here to go to Edwards website
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Eur J Cardiothorac Surg 2009;35:193. doi:10.1016/j.ejcts.2008.10.019
Copyright © 2009, European Association for Cardio-thoracic Surgery. Published by Elsevier. All rights reserved.

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Dimitrios Dougenis
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Apostolakis, E. E.
Right arrow Articles by Dougenis, D.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Apostolakis, E. E.
Right arrow Articles by Dougenis, D.
Related Collections
Right arrow Lung - other
Right arrow Pleura


Letters to the Editor

Are procalcitonin levels sufficient for the follow up of patients undergoing lung decortication for pleural empyema?

Efstratios E. Apostolakis*, Christos Prokakis, Dimitrios Dougenis

Cardiothoracic Surgery Department, Patras University, School of Medicine, 14 Zaimi Street, 26500, Rion Patras, Greece

Received 11 August 2008; accepted 21 October 2008.

* Corresponding author. Tel.: +30 2610 999779/999847; fax: +30 2610 994535. (Email: stratisapostolakis{at}yahoo.gr).

Key Words: Pleural empyema • Inflammation • Procalcitonin • C-reactive protein • Lung decortication

We have read with interest the comparative study on the role of procalcitonin (PCT) and C-reactive protein (CrP) in the monitoring of the postoperative course after decortication for pleural empyema [1]. Nevertheless some issues should be pointed out: (A) the small number of patients in each subgroup impacts on the validity of the results, especially as far as postoperative complications concerns. (B) The preoperative values of PTC were lower than the ones in the first postoperative day and even lower than those measured at the second day after lung decortication. This does not seem coherent to the comment that ‘In pleural empyema elevated CrP and PCT value is expected to increase preoperatively because of the infection. But after the removal of the damaged and infectious tissue both the CrP and PCT values should decrease rapidly’. A possible explanation for the increasing values of both CrP and PCT in the days following lung decortication could be the release of endotoxins and ‘inflammation spreading’ during surgery. Indeed it is known that endotoxin administration is associated with a dramatic increase of PCT levels after 3 to 4 h, reaching its peak after 24 h followed by a return to normal levels a few days later [2]. Furthermore, how do you explain the fact that one of your patients who developed postoperative recurrent pleural effusions with persisting high levels of PCT also presented low PCT preoperatively? Our major concern is that the variation of PCT levels could be related to other perioperative factors rather than the decortications itself. Patients undergoing cardiac procedures present perioperative variation of PCT levels similar to the ones in this study [3,4]. The use of CPB, a known factor promoting systemic inflammation, does not seem to have an impact on the pattern of increase of PCT levels in the postoperative period [4]. At this point it should be mentioned that a known trigger for PCT production is the release of cytokines in response to tissue injury associated with every surgical procedure [5]. (C) One of the reported criteria for the definition of empyema and patient inclusion in the study was the detection of bacteria in pleural effusion while an exclusion criterion was the presence of tuberculosis. However this succeeded in only 31.8% of the patients. How did you exclude the possibility of false negative culture for tuberculosis among the patients with negative cultures, and if there were such patients how do you explain the decrease of PTC levels in all patients in the postoperative period even though tuberculosis is related to persisting inflammation not controlled by lung decortication? (D) The decision for continuing antibiotic therapy after discharge was based on CrP values since all PCT values were not available during hospitalization as you stated. Would an earlier availability of these values have an impact on the decision to proceed with antibiotics after patient discharge? In our opinion further randomized trials with larger study groups are necessary to clarify the role of PCT as a measure to monitor the outcome after surgical management of infectious and septic conditions.

References

  1. Carboni GL, Fahrner R, Gazdhar A, Printzen G, Schmid RA, Hoksch B. Comparison of precalcitonin and CrP in the postoperative course after lung decortication. Eur J Cardiothorac Surg 2008;33:777-780.[Abstract/Free Full Text]
  2. Maruna P, Nedelnikova R, Gurlich R. Physiology and genetics of procalcitonin. Physiol Res 2000;49:S57-S61.[Medline]
  3. Kilger E, Pichler B, Goetz AE, Rank N, Welte M, Mörstedt K, Vetter HO, Gödje O, Schmitz C, Lamm P, Engelschalk E, Muehlbeyer D, Frey L. Procalcitonin as a marker of systemic inflammation after conventional or minimally invasive coronary artery bypass grafting. Thorac Cardiovasc Surg 1998;46:130-133.[Medline]
  4. Aouifi A, Piriou V, Blanc P, Bouvier H, Bastien O, Chiari P, Rousson R, Evans R, Lehot JJ. Effect of cardiopulmonary bypass on serum procalcitonin and C-reactive protein concentrations. Br J Anaest 1999;83:602-607.[Abstract/Free Full Text]
  5. Meisner M. Pathobiochemistry and clinical use of procalcitonin. Clin Chim Acta 2002;323:17-29.[CrossRef][Medline]



This article has been cited by other articles:


Home page
Eur. J. Cardiothorac. Surg.Home page
T. Guenther, D. Mazzitelli, and R. Lange
Reply to Elsayed and Poullis
Eur. J. Cardiothorac. Surg., January 1, 2009; 35(1): 192 - 193.
[Full Text] [PDF]


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Dimitrios Dougenis
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Apostolakis, E. E.
Right arrow Articles by Dougenis, D.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Apostolakis, E. E.
Right arrow Articles by Dougenis, D.
Related Collections
Right arrow Lung - other
Right arrow Pleura


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS